Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: Five cases

W. Park, N. K. Kim, M. Y. Kim, Yumie Rhee, H. J. Kim

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can occur irrespective of race. Old age and long-term use of corticosteroid may be a more reliable risk factor than racial characteristics. Introduction: BRONJ is an increasingly common problem. Most BRONJ occurs following an intravenous administration of bisphosphonate treatment for malignant bone disease and metastatic cancer. As the incidence of BRONJ caused by oral administration of bisphosphonate is quite low, it is believed that this medication is relatively safe and effective in preventing complications of osteoporosis, such as hip or spine fractures. The many known risk factors for BRONJ can be classified as drug-related, local, demographic, and systemic. One demographic and systemic risk factor is race. Most of the case reports of BRONJ present elderly, white women. Methods: In this report, we describe five cases of BRONJ caused by oral administration of bisphosphonate in Asian population. Results: All the patients were female and over 65 years old. Three patients had been prescribed with corticosteroids for rheumatoid arthritis. Conclusion: Irrespective of race, elderly women undergoing steroid therapy have an increased incidence of BRONJ even with oral administration of bisphosphonate.

Original languageEnglish
Pages (from-to)527-533
Number of pages7
JournalOsteoporosis International
Volume21
Issue number3
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Osteonecrosis
Diphosphonates
Jaw
Oral Administration
Population
Adrenal Cortex Hormones
Demography
Bone Diseases
Incidence
Intravenous Administration
Osteoporosis
Hip
Rheumatoid Arthritis
Spine
Steroids

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism

Cite this

@article{25b28a090f8242f78d4a8f1a8b7d616c,
title = "Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: Five cases",
abstract = "Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can occur irrespective of race. Old age and long-term use of corticosteroid may be a more reliable risk factor than racial characteristics. Introduction: BRONJ is an increasingly common problem. Most BRONJ occurs following an intravenous administration of bisphosphonate treatment for malignant bone disease and metastatic cancer. As the incidence of BRONJ caused by oral administration of bisphosphonate is quite low, it is believed that this medication is relatively safe and effective in preventing complications of osteoporosis, such as hip or spine fractures. The many known risk factors for BRONJ can be classified as drug-related, local, demographic, and systemic. One demographic and systemic risk factor is race. Most of the case reports of BRONJ present elderly, white women. Methods: In this report, we describe five cases of BRONJ caused by oral administration of bisphosphonate in Asian population. Results: All the patients were female and over 65 years old. Three patients had been prescribed with corticosteroids for rheumatoid arthritis. Conclusion: Irrespective of race, elderly women undergoing steroid therapy have an increased incidence of BRONJ even with oral administration of bisphosphonate.",
author = "W. Park and Kim, {N. K.} and Kim, {M. Y.} and Yumie Rhee and Kim, {H. J.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1007/s00198-009-0973-3",
language = "English",
volume = "21",
pages = "527--533",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "3",

}

Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population : Five cases. / Park, W.; Kim, N. K.; Kim, M. Y.; Rhee, Yumie; Kim, H. J.

In: Osteoporosis International, Vol. 21, No. 3, 01.03.2010, p. 527-533.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population

T2 - Five cases

AU - Park, W.

AU - Kim, N. K.

AU - Kim, M. Y.

AU - Rhee, Yumie

AU - Kim, H. J.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can occur irrespective of race. Old age and long-term use of corticosteroid may be a more reliable risk factor than racial characteristics. Introduction: BRONJ is an increasingly common problem. Most BRONJ occurs following an intravenous administration of bisphosphonate treatment for malignant bone disease and metastatic cancer. As the incidence of BRONJ caused by oral administration of bisphosphonate is quite low, it is believed that this medication is relatively safe and effective in preventing complications of osteoporosis, such as hip or spine fractures. The many known risk factors for BRONJ can be classified as drug-related, local, demographic, and systemic. One demographic and systemic risk factor is race. Most of the case reports of BRONJ present elderly, white women. Methods: In this report, we describe five cases of BRONJ caused by oral administration of bisphosphonate in Asian population. Results: All the patients were female and over 65 years old. Three patients had been prescribed with corticosteroids for rheumatoid arthritis. Conclusion: Irrespective of race, elderly women undergoing steroid therapy have an increased incidence of BRONJ even with oral administration of bisphosphonate.

AB - Bisphosphonate-related osteonecrosis of the jaw (BRONJ) can occur irrespective of race. Old age and long-term use of corticosteroid may be a more reliable risk factor than racial characteristics. Introduction: BRONJ is an increasingly common problem. Most BRONJ occurs following an intravenous administration of bisphosphonate treatment for malignant bone disease and metastatic cancer. As the incidence of BRONJ caused by oral administration of bisphosphonate is quite low, it is believed that this medication is relatively safe and effective in preventing complications of osteoporosis, such as hip or spine fractures. The many known risk factors for BRONJ can be classified as drug-related, local, demographic, and systemic. One demographic and systemic risk factor is race. Most of the case reports of BRONJ present elderly, white women. Methods: In this report, we describe five cases of BRONJ caused by oral administration of bisphosphonate in Asian population. Results: All the patients were female and over 65 years old. Three patients had been prescribed with corticosteroids for rheumatoid arthritis. Conclusion: Irrespective of race, elderly women undergoing steroid therapy have an increased incidence of BRONJ even with oral administration of bisphosphonate.

UR - http://www.scopus.com/inward/record.url?scp=76549104416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76549104416&partnerID=8YFLogxK

U2 - 10.1007/s00198-009-0973-3

DO - 10.1007/s00198-009-0973-3

M3 - Article

C2 - 19484166

AN - SCOPUS:76549104416

VL - 21

SP - 527

EP - 533

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 3

ER -